A consensus guideline of herbal medicine for coronavirus disease 2019
The Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2), which originated in Wuhan, Hubei Province, China in late December 2019, is the cause of ongoing pandemic. We analyzed the symptoms of SARS-CoV-2, a classification of the Chinese medicine dialectic and treatment regimen, and promptly ena...
Saved in:
| Published in | Integrative medicine research Vol. 9; no. 3; pp. 100470 - 4 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Netherlands
Elsevier B.V
01.09.2020
Elsevier 한국한의학연구원 |
| Subjects | |
| Online Access | Get full text |
| ISSN | 2213-4220 2213-4239 2213-4239 |
| DOI | 10.1016/j.imr.2020.100470 |
Cover
| Abstract | The Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2), which originated in Wuhan, Hubei Province, China in late December 2019, is the cause of ongoing pandemic. We analyzed the symptoms of SARS-CoV-2, a classification of the Chinese medicine dialectic and treatment regimen, and promptly enacted the recommendation of Korean medicine preparations in herbal medicine covered under domestic medical insurance benefits depending on the circumstances in our country.
The clinical practice guideline (CPG) for the treatment of SARS-CoV-2 was developed based on consensus from a group of experts.
Two kinds of herbal medicines (HM) were recommended for the prevention of SARS-CoV-2; Youngyopaedoc-san plus Bojungikgitang, and Youngyopaedoc-san plus Saengmaek-san. Two herbal preparations were recommended for people with a history of exposure to SARS-CoV-2; Youngyopaedoc-san plus Bulhwangeumjeonggi-san, and Youngyopaedoc-san plus Bojungikgi-tang. Three herbal preparations were recommended for mildly symptomatic COVID-19 patients; Youngyopaedoc-san plus Galgunhaegui-tang was recommended for those without pneumonia with wind-warmth disease invading the lungs; Sosiho-tang plus Bulhwangeumjeonggi-san was recommended for those with dampness-heat disease in the lungs. For the recovery stage, Samchulkunbi-tang plus Saengmaek-san, or Samchulkunbi-tang plus Chungseuiki-tang was recommended.
The CPG was developed to guide the use of Korean herbal medicine in the treatment of SARS-CoV-2, and it is expected that this will be the basis for providing proper treatment of similar infectious diseases in the future. |
|---|---|
| AbstractList | Background: The Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2), which originated in Wuhan, Hubei Province, China in late December 2019, is the cause of ongoing pandemic. We analyzed the symptoms of SARS-CoV-2, a classification of the Chinese medicine dialectic and treatment regimen, and promptly enacted the recommendation of Korean medicine preparations in herbal medicine covered under domestic medical insurance benefits depending on the circumstances in our country.
Method: The clinical practice guideline (CPG) for the treatment of SARS-CoV-2 was developed based on consensus from a group of experts.
Results: Two kinds of herbal medicines (HM) were recommended for the prevention of SARS-CoV-2; Youngyopaedoc-san plus Bojungikgitang, and Youngyopaedoc-san plus Saengmaek-san. Two herbal preparations were recommended for people with a history of exposure to SARS-CoV-2; Youngyopaedoc-san plus Bulhwangeumjeonggi-san, and Youngyopaedoc-san plus Bojungikgi-tang. Three herbal preparations were recommended for mildly symptomatic COVID-19 patients; Youngyopaedoc-san plus Galgunhaegui-tang was recommended for those without pneumonia with wind-warmth disease invading the lungs; Sosiho-tang plus Bulhwangeumjeonggi-san was recommended for those with dampness-heat disease in the lungs. For the recovery stage, Samchulkunbi-tang plus Saengmaek-san, or Samchulkunbi-tang plus Chungseuiki-tang was recommended.
Conclusion: The CPG was developed to guide the use of Korean herbal medicine in the treatment of SARS-CoV-2, and it is expected that this will be the basis for providing proper treatment of similar infectious diseases in the future. KCI Citation Count: 21 The Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2), which originated in Wuhan, Hubei Province, China in late December 2019, is the cause of ongoing pandemic. We analyzed the symptoms of SARS-CoV-2, a classification of the Chinese medicine dialectic and treatment regimen, and promptly enacted the recommendation of Korean medicine preparations in herbal medicine covered under domestic medical insurance benefits depending on the circumstances in our country. The clinical practice guideline (CPG) for the treatment of SARS-CoV-2 was developed based on consensus from a group of experts. Two kinds of herbal medicines (HM) were recommended for the prevention of SARS-CoV-2; Youngyopaedoc-san plus Bojungikgitang, and Youngyopaedoc-san plus Saengmaek-san. Two herbal preparations were recommended for people with a history of exposure to SARS-CoV-2; Youngyopaedoc-san plus Bulhwangeumjeonggi-san, and Youngyopaedoc-san plus Bojungikgi-tang. Three herbal preparations were recommended for mildly symptomatic COVID-19 patients; Youngyopaedoc-san plus Galgunhaegui-tang was recommended for those without pneumonia with wind-warmth disease invading the lungs; Sosiho-tang plus Bulhwangeumjeonggi-san was recommended for those with dampness-heat disease in the lungs. For the recovery stage, Samchulkunbi-tang plus Saengmaek-san, or Samchulkunbi-tang plus Chungseuiki-tang was recommended. The CPG was developed to guide the use of Korean herbal medicine in the treatment of SARS-CoV-2, and it is expected that this will be the basis for providing proper treatment of similar infectious diseases in the future. The Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2), which originated in Wuhan, Hubei Province, China in late December 2019, is the cause of ongoing pandemic. We analyzed the symptoms of SARS-CoV-2, a classification of the Chinese medicine dialectic and treatment regimen, and promptly enacted the recommendation of Korean medicine preparations in herbal medicine covered under domestic medical insurance benefits depending on the circumstances in our country.BACKGROUNDThe Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2), which originated in Wuhan, Hubei Province, China in late December 2019, is the cause of ongoing pandemic. We analyzed the symptoms of SARS-CoV-2, a classification of the Chinese medicine dialectic and treatment regimen, and promptly enacted the recommendation of Korean medicine preparations in herbal medicine covered under domestic medical insurance benefits depending on the circumstances in our country.The clinical practice guideline (CPG) for the treatment of SARS-CoV-2 was developed based on consensus from a group of experts.METHODThe clinical practice guideline (CPG) for the treatment of SARS-CoV-2 was developed based on consensus from a group of experts.Two kinds of herbal medicines (HM) were recommended for the prevention of SARS-CoV-2; Youngyopaedoc-san plus Bojungikgitang, and Youngyopaedoc-san plus Saengmaek-san. Two herbal preparations were recommended for people with a history of exposure to SARS-CoV-2; Youngyopaedoc-san plus Bulhwangeumjeonggi-san, and Youngyopaedoc-san plus Bojungikgi-tang. Three herbal preparations were recommended for mildly symptomatic COVID-19 patients; Youngyopaedoc-san plus Galgunhaegui-tang was recommended for those without pneumonia with wind-warmth disease invading the lungs; Sosiho-tang plus Bulhwangeumjeonggi-san was recommended for those with dampness-heat disease in the lungs. For the recovery stage, Samchulkunbi-tang plus Saengmaek-san, or Samchulkunbi-tang plus Chungseuiki-tang was recommended.RESULTSTwo kinds of herbal medicines (HM) were recommended for the prevention of SARS-CoV-2; Youngyopaedoc-san plus Bojungikgitang, and Youngyopaedoc-san plus Saengmaek-san. Two herbal preparations were recommended for people with a history of exposure to SARS-CoV-2; Youngyopaedoc-san plus Bulhwangeumjeonggi-san, and Youngyopaedoc-san plus Bojungikgi-tang. Three herbal preparations were recommended for mildly symptomatic COVID-19 patients; Youngyopaedoc-san plus Galgunhaegui-tang was recommended for those without pneumonia with wind-warmth disease invading the lungs; Sosiho-tang plus Bulhwangeumjeonggi-san was recommended for those with dampness-heat disease in the lungs. For the recovery stage, Samchulkunbi-tang plus Saengmaek-san, or Samchulkunbi-tang plus Chungseuiki-tang was recommended.The CPG was developed to guide the use of Korean herbal medicine in the treatment of SARS-CoV-2, and it is expected that this will be the basis for providing proper treatment of similar infectious diseases in the future.CONCLUSIONThe CPG was developed to guide the use of Korean herbal medicine in the treatment of SARS-CoV-2, and it is expected that this will be the basis for providing proper treatment of similar infectious diseases in the future. Background: The Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2), which originated in Wuhan, Hubei Province, China in late December 2019, is the cause of ongoing pandemic. We analyzed the symptoms of SARS-CoV-2, a classification of the Chinese medicine dialectic and treatment regimen, and promptly enacted the recommendation of Korean medicine preparations in herbal medicine covered under domestic medical insurance benefits depending on the circumstances in our country. Method: The clinical practice guideline (CPG) for the treatment of SARS-CoV-2 was developed based on consensus from a group of experts. Results: Two kinds of herbal medicines (HM) were recommended for the prevention of SARS-CoV-2; Youngyopaedoc-san plus Bojungikgitang, and Youngyopaedoc-san plus Saengmaek-san. Two herbal preparations were recommended for people with a history of exposure to SARS-CoV-2; Youngyopaedoc-san plus Bulhwangeumjeonggi-san, and Youngyopaedoc-san plus Bojungikgi-tang. Three herbal preparations were recommended for mildly symptomatic COVID-19 patients; Youngyopaedoc-san plus Galgunhaegui-tang was recommended for those without pneumonia with wind-warmth disease invading the lungs; Sosiho-tang plus Bulhwangeumjeonggi-san was recommended for those with dampness-heat disease in the lungs. For the recovery stage, Samchulkunbi-tang plus Saengmaek-san, or Samchulkunbi-tang plus Chungseuiki-tang was recommended. Conclusion: The CPG was developed to guide the use of Korean herbal medicine in the treatment of SARS-CoV-2, and it is expected that this will be the basis for providing proper treatment of similar infectious diseases in the future. |
| ArticleNumber | 100470 |
| Author | Kim, Kwan-Il Jung, Hee-Jae Lee, Beom-Joon Lee, Ju Ah Choi, Jun-Yong |
| Author_xml | – sequence: 1 givenname: Beom-Joon orcidid: 0000-0003-4205-1175 surname: Lee fullname: Lee, Beom-Joon organization: Division of Allergy, Immune and Respiratory System, Department of Internal Medicine, College of Korean Medicine, Kyung Hee University Seoul, Republic of Korea – sequence: 2 givenname: Ju Ah orcidid: 0000-0003-3207-6109 surname: Lee fullname: Lee, Ju Ah organization: Hwapyeong Institute of Integrative Medicine, Incheon, Republic of Korea – sequence: 3 givenname: Kwan-Il orcidid: 0000-0002-8071-3881 surname: Kim fullname: Kim, Kwan-Il organization: Division of Allergy, Immune and Respiratory System, Department of Internal Medicine, College of Korean Medicine, Kyung Hee University Seoul, Republic of Korea – sequence: 4 givenname: Jun-Yong orcidid: 0000-0002-2854-3862 surname: Choi fullname: Choi, Jun-Yong email: kmd@pusan.ac.kr organization: Korean Medicine Hospital of Pusan National University, Gyeongsangnam-do, Republic of Korea – sequence: 5 givenname: Hee-Jae orcidid: 0000-0001-7384-6881 surname: Jung fullname: Jung, Hee-Jae email: hanfish@khmc.or.kr organization: Division of Allergy, Immune and Respiratory System, Department of Internal Medicine, College of Korean Medicine, Kyung Hee University Seoul, Republic of Korea |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32691002$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002626110$$DAccess content in National Research Foundation of Korea (NRF) |
| BookMark | eNqNkktvEzEUhUeoiJbSH8AGZQmLBL9m7BESUlQViFQJCZW15cd16nRiB3smqP8eT6ZElEXBG7--c3Ttc19WJyEGqKrXGC0wws37zcJv04IgMu4R4-hZdUYIpnNGaHtyXBN0Wl3kvEFltByRmr-oTilp2iIiZ9XVcmZiyBDykGfrwVvofIBZdLNbSFp1sy1Yb8YjF1NBUwxq71OBrc-gMswIwu2r6rlTXYaLh_m8-v7p6ubyy_z66-fV5fJ6bmrB-rnTTFmGjFXI1Q7KTreaWVK7RlsEwjpRI2aMY1RrzQWzDgnhlGPIIg6WnlfvJt-QnLwzXkblD_M6yrskl99uVrKteU0xKexqYm1UG7lLfqvS_UFwOIhpLVXqvelA1kYI6lrFGaXMKqWbBjvXWCwMJrXSxYtMXkPYqfufquuOhhjJMQ65kSUOOcYhpziK6OMk2g26_KKB0CfVPark8U3wt-Uhe8kprZloi8HbB4MUfwyQe7n12UDXqQBxyJLUohUl7cL_E2UjzAjnBX3zZ1nHen73RAH4BJgUc07gpPG96n0cq_Tdky_Gfyn_55c-TBoofbP3kGQ2HoIpbZfA9CUs_4T6F9GB8P8 |
| CitedBy_id | crossref_primary_10_1097_HM9_0000000000000043 crossref_primary_10_31083_j_fbl2705152 crossref_primary_10_1016_j_phymed_2022_154136 crossref_primary_10_1016_j_phrs_2021_105472 crossref_primary_10_1007_s43441_020_00224_1 crossref_primary_10_1016_j_imr_2020_100496 crossref_primary_10_1080_21655979_2022_2036521 crossref_primary_10_1007_s42398_022_00230_z crossref_primary_10_1556_650_2021_32327 crossref_primary_10_1016_j_totert_2022_100010 crossref_primary_10_31083_j_rcm_2020_03_118 crossref_primary_10_3389_fmed_2021_630765 crossref_primary_10_1016_j_tifs_2021_07_037 crossref_primary_10_1016_j_jhazmat_2024_137016 crossref_primary_10_2147_TCRM_S405507 crossref_primary_10_1016_j_imr_2024_101022 crossref_primary_10_1080_07391102_2021_1922095 crossref_primary_10_3389_fcimb_2022_929430 crossref_primary_10_1002_imt2_42 crossref_primary_10_1155_2022_7303393 crossref_primary_10_3389_fmed_2022_884573 crossref_primary_10_15188_kjopp_2022_12_36_6_242 crossref_primary_10_1016_j_apsb_2021_09_008 crossref_primary_10_1111_jep_13614 |
| Cites_doi | 10.3390/ijms21072657 10.1002/jia2.25489 10.7150/ijbs.45538 |
| ContentType | Journal Article |
| Copyright | 2020 2020 Korea Institute of Oriental Medicine. Publishing services by Elsevier B.V. 2020 Korea Institute of Oriental Medicine. Publishing services by Elsevier B.V. 2020 |
| Copyright_xml | – notice: 2020 – notice: 2020 Korea Institute of Oriental Medicine. Publishing services by Elsevier B.V. – notice: 2020 Korea Institute of Oriental Medicine. Publishing services by Elsevier B.V. 2020 |
| DBID | 6I. AAFTH AAYXX CITATION NPM 7X8 5PM ADTOC UNPAY DOA ACYCR |
| DOI | 10.1016/j.imr.2020.100470 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall DOAJ Directory of Open Access Journals Korean Citation Index |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2213-4239 |
| EndPage | 4 |
| ExternalDocumentID | oai_kci_go_kr_ARTI_9575312 oai_doaj_org_article_5c883f9a74334daab661ff6d18c125ab 10.1016/j.imr.2020.100470 PMC7335489 32691002 10_1016_j_imr_2020_100470 S2213422020301025 |
| Genre | Journal Article |
| GroupedDBID | .~1 0R~ 0SF 1~. 4.4 457 4G. 5VS 6I. 7-5 AACTN AAEDT AAEDW AAFTH AAIKJ AALRI AAXUO ABMAC ACGFS ADBBV ADEZE AEKER AEXQZ AFTJW AGHFR AGYEJ AITUG AJRQY ALMA_UNASSIGNED_HOLDINGS AMRAJ AOIJS BCNDV EBS EJD FDB FEDTE FNPLU GBLVA GROUPED_DOAJ HVGLF HYE HZ~ IPNFZ KQ8 MO0 NCXOZ O-L O9- OK1 P-8 P-9 PC. Q38 RIG ROL RPM SDF SSZ AAYWO AAYXX ACVFH ADCNI ADVLN AEUPX AFPUW AIGII AKBMS AKRWK AKYEP CITATION ~HD NPM 7X8 5PM ADTOC UNPAY ACYCR |
| ID | FETCH-LOGICAL-c584t-fb4ad40cda0f5feb4ab9b4d25f6bd0e8df8504ccf43bbb784df088faf40d07ed3 |
| IEDL.DBID | DOA |
| ISSN | 2213-4220 2213-4239 |
| IngestDate | Tue Jun 25 21:05:17 EDT 2024 Fri Oct 03 12:43:29 EDT 2025 Sun Oct 26 04:12:58 EDT 2025 Tue Sep 30 16:36:27 EDT 2025 Tue Sep 30 21:55:52 EDT 2025 Sun Sep 28 00:09:27 EDT 2025 Thu Jan 02 22:54:45 EST 2025 Wed Oct 01 00:44:05 EDT 2025 Thu Apr 24 23:02:33 EDT 2025 Fri Feb 23 02:47:04 EST 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | Korean medicine Herbal medicine SARS-CoV-2 Clinical practice guideline |
| Language | English |
| License | This is an open access article under the CC BY-NC-ND license. 2020 Korea Institute of Oriental Medicine. Publishing services by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). cc-by-nc-nd |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c584t-fb4ad40cda0f5feb4ab9b4d25f6bd0e8df8504ccf43bbb784df088faf40d07ed3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 These authors contributed equally to this work. https://www.sciencedirect.com/science/article/pii/S2213422020301025#! |
| ORCID | 0000-0001-7384-6881 0000-0003-4205-1175 0000-0002-2854-3862 0000-0003-3207-6109 0000-0002-8071-3881 |
| OpenAccessLink | https://doaj.org/article/5c883f9a74334daab661ff6d18c125ab |
| PMID | 32691002 |
| PQID | 2425894277 |
| PQPubID | 23479 |
| PageCount | 4 |
| ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_9575312 doaj_primary_oai_doaj_org_article_5c883f9a74334daab661ff6d18c125ab unpaywall_primary_10_1016_j_imr_2020_100470 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7335489 proquest_miscellaneous_2589842373 proquest_miscellaneous_2425894277 pubmed_primary_32691002 crossref_citationtrail_10_1016_j_imr_2020_100470 crossref_primary_10_1016_j_imr_2020_100470 elsevier_sciencedirect_doi_10_1016_j_imr_2020_100470 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2020-09-01 |
| PublicationDateYYYYMMDD | 2020-09-01 |
| PublicationDate_xml | – month: 09 year: 2020 text: 2020-09-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | Integrative medicine research |
| PublicationTitleAlternate | Integr Med Res |
| PublicationYear | 2020 |
| Publisher | Elsevier B.V Elsevier 한국한의학연구원 |
| Publisher_xml | – name: Elsevier B.V – name: Elsevier – name: 한국한의학연구원 |
| References | National Health Commission of People’s Republic of China. Diagnosis and treatment of pneumonia caused by novel coronavirus (trial version 7. http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989/files/ce3e6945832a438eaae415350a8ce964.pdf (Accessed on March 06, 2020). Tu, Chien, Yarmishyn, Lin, Luo, Lin (bib0030) 2020; 21 Wang, Yang, Xie, Shen, Li, Le (bib0040) 2020; 36 Yang, Islam, Wang, Li, Chen (bib0035) 2020; 16 Guideline Center for Korean Medicine and The Society of Internal Korean Medicine (bib0015) 2017 World Health Organization. Coronavirus disease (COVID-19) Pandemic. https://covid19.who.int/ (Accessed on April 17, 2020). [Available from: https://covid19.who.int/. Xu, Xu, Wang, Lü, Zhu, Song (bib0045) 2020; 36 Ford, Vitoria, Rangaraj, Norris, Calmy, Doherty (bib0025) 2020; 23 World Health Organization. Coronavirus disease 2019 (COVID-19) Situation report - 44. March 04, 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports (Accessed on March 06, 2020). Guideline Center for Korean Medicine and The Society of Internal Korean Medicine (10.1016/j.imr.2020.100470_bib0015) 2017 10.1016/j.imr.2020.100470_bib0010 10.1016/j.imr.2020.100470_bib0020 Tu (10.1016/j.imr.2020.100470_bib0030) 2020; 21 10.1016/j.imr.2020.100470_bib0005 Wang (10.1016/j.imr.2020.100470_bib0040) 2020; 36 Yang (10.1016/j.imr.2020.100470_bib0035) 2020; 16 Xu (10.1016/j.imr.2020.100470_bib0045) 2020; 36 Ford (10.1016/j.imr.2020.100470_bib0025) 2020; 23 |
| References_xml | – reference: National Health Commission of People’s Republic of China. Diagnosis and treatment of pneumonia caused by novel coronavirus (trial version 7. http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989/files/ce3e6945832a438eaae415350a8ce964.pdf (Accessed on March 06, 2020). – volume: 23 year: 2020 ident: bib0025 article-title: Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID-19: initial assessment publication-title: J Int AIDS Soc – year: 2017 ident: bib0015 article-title: Korean medicine clinical practice guideline for Common cold (pre-certified version) – volume: 16 start-page: 1708 year: 2020 end-page: 1717 ident: bib0035 article-title: Traditional Chinese medicine in the treatment of patients infected with 2019-New coronavirus (SARS-CoV-2): a review and perspective publication-title: Int J Biol Sci. – reference: World Health Organization. Coronavirus disease 2019 (COVID-19) Situation report - 44. March 04, 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports (Accessed on March 06, 2020). – volume: 21 year: 2020 ident: bib0030 article-title: A review of SARS-CoV-2 and the ongoing clinical trials publication-title: Int J Mol Sci – volume: 36 start-page: 13 year: 2020 end-page: 18 ident: bib0040 article-title: Clinical observation of qingfeipaidu decoction in the treatment of COVID-19 publication-title: Pharmacol Clinics Chin Materia Medica – reference: World Health Organization. Coronavirus disease (COVID-19) Pandemic. https://covid19.who.int/ (Accessed on April 17, 2020). [Available from: https://covid19.who.int/. – volume: 36 start-page: 26 year: 2020 end-page: 32 ident: bib0045 article-title: Mechanism of qingfeipaidu decoction on COVID-19 based on network pharmacology publication-title: Clin Chin Materia Medica – year: 2017 ident: 10.1016/j.imr.2020.100470_bib0015 – volume: 21 year: 2020 ident: 10.1016/j.imr.2020.100470_bib0030 article-title: A review of SARS-CoV-2 and the ongoing clinical trials publication-title: Int J Mol Sci doi: 10.3390/ijms21072657 – volume: 36 start-page: 13 year: 2020 ident: 10.1016/j.imr.2020.100470_bib0040 article-title: Clinical observation of qingfeipaidu decoction in the treatment of COVID-19 publication-title: Pharmacol Clinics Chin Materia Medica – volume: 23 year: 2020 ident: 10.1016/j.imr.2020.100470_bib0025 article-title: Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID-19: initial assessment publication-title: J Int AIDS Soc doi: 10.1002/jia2.25489 – volume: 16 start-page: 1708 year: 2020 ident: 10.1016/j.imr.2020.100470_bib0035 article-title: Traditional Chinese medicine in the treatment of patients infected with 2019-New coronavirus (SARS-CoV-2): a review and perspective publication-title: Int J Biol Sci. doi: 10.7150/ijbs.45538 – ident: 10.1016/j.imr.2020.100470_bib0010 – ident: 10.1016/j.imr.2020.100470_bib0020 – volume: 36 start-page: 26 year: 2020 ident: 10.1016/j.imr.2020.100470_bib0045 article-title: Mechanism of qingfeipaidu decoction on COVID-19 based on network pharmacology publication-title: Clin Chin Materia Medica – ident: 10.1016/j.imr.2020.100470_bib0005 |
| SSID | ssj0000970257 |
| Score | 2.2503302 |
| Snippet | The Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2), which originated in Wuhan, Hubei Province, China in late December 2019, is the cause of ongoing... Background: The Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2), which originated in Wuhan, Hubei Province, China in late December 2019, is the... |
| SourceID | nrf doaj unpaywall pubmedcentral proquest pubmed crossref elsevier |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 100470 |
| SubjectTerms | Clinical practice guideline Herbal medicine Korean medicine Original SARS-CoV-2 학제간연구 |
| SummonAdditionalLinks | – databaseName: Science Direct dbid: .~1 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKD8AF8Sa8FBAnUFgnsRP7WKpWBalcoFJvlh_xErokq-ymFRd-OzN5qRFokThFccaJ8nlif86MPxPyhlPtgdZnkdG6iJgTRWS8jKOUcSOMtZx367hPP2cnZ-zTOT_fI4fjWhhMqxz6_r5P73rroWQxoLlYl-XiS4JiZEmCoTQURsOF5ozluIvB-1_x9J-Fypz2gp9oH2GFMbjZpXmVP1AVNOnSBRhuWXxteOpU_Gej1I2q8X_jon-mVN5qq7X-eaVXq2vj1fFdcmcgmuFB_y73yF5R3Sc3T4dQ-gNydBBazKSuNu0mXLaodgXlYe1DaEUDNceoewi0FkwboOyXZQPGQ0wnhEFdPiRnx0dfD0-iYU-FyALq28gbph2j1mnquS_gzEjDXMJ9ZhwthPOCU2atZ6kxJhfMeeiHvPaMOpoXLn1E9qu6Kp6Q0HPpnOXOCM6Y1N4kceG49pkVHlXBAkJHKJUdBMdx34uVGjPLvitAXyH6qkc_IG-nKutebWOX8Qdsn8kQhbK7grpZqsFTFLdCpF5qIEopc1ob4CPeZy4WFqidNgFhY-uqmd_Brcpdz34NnqAubNk9Fo_LWl00CmYhH5UEDpzGSUBejY6i4KPFSIyuirrdKJznCcmSPN9hAxYCk5bSgDzunWt6VeDcErVzA5LP3G6GxfxKVX7rxMPzNIVJKjTOu8lB_w310_9D6Rm5jWd9St5zsr9t2uIFcLitedl9pL8BXOZDUA priority: 102 providerName: Elsevier – databaseName: Unpaywall dbid: UNPAY link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lj9MwELagKwEX3o_wUkCcQFmlsZ04x4J2tSDtigOVlpPl1yyhJV2lDQh-PePEqQisCpwSJ2NHnhnHnzXjz4S84KkChPV5opVyCbPCJRrKaUIZ10Ibw3m3j_v4JD-as3en_DSQRfu9MKP4fZeHVX3xtJ1ZF89nBa7O93KOsHtC9uYn72cf_eFx2ZQmLOsoGMM9LYcI5kVtjOagjqp_NBVdrhu4CHD-mTd5ta3P1fdvarn8ZVI6vNGnc607LkOfi7LYbzd63_z4jenxn_p7k1wP0DSe9b50i1xy9W1y5TgE3--Qg1lsfO51vW7X8Vnr-bHwebyCGO2useYQp48RCKNogyD_a9WgcIgCxQgDyrtkfnjw4c1REk5hSAzaaZOAZsqy1FiVAgeHJV1qZjMOubapExYET5kxwKjWuhDMAv65QAFLbVo4S--RSb2q3QMSAy-tNdxqwRkrFehs6ixXkBsBnkcsIulgF2kCRbk_KWMph1y0zxLVI716ZK-eiLzcVjnv-Tl2Cb_2xt4Kemrt7gFaQIaRKrkRgkKpEFpRZpXSiGAAcjsVBsGg0hFhg6vIgFJ69IFNVbu-_RzdSi5M1X3WX89WctFIXLe8lSWiZjrNIvJs8DqJw9zHblTtVu1a-pWhKFlWFDtkUEL4NCcakfu9p267iii99Gy7ESlGPjzSxfhNXX3q6MYLSnFZi8Z5tfX2v6v64X9JPyLXfKnP3XtMJpumdU8Q7G300zDMfwJMZ0ze priority: 102 providerName: Unpaywall |
| Title | A consensus guideline of herbal medicine for coronavirus disease 2019 |
| URI | https://dx.doi.org/10.1016/j.imr.2020.100470 https://www.ncbi.nlm.nih.gov/pubmed/32691002 https://www.proquest.com/docview/2425894277 https://www.proquest.com/docview/2589842373 https://pubmed.ncbi.nlm.nih.gov/PMC7335489 https://doi.org/10.1016/j.imr.2020.100470 https://doaj.org/article/5c883f9a74334daab661ff6d18c125ab https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002626110 |
| UnpaywallVersion | publishedVersion |
| Volume | 9 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | Integrative Medicine Research, 2020, 9(3), 32, pp.1-4 |
| journalDatabaseRights | – providerCode: PRVAFT databaseName: Colorado Digital library customDbUrl: eissn: 2213-4239 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000970257 issn: 2213-4220 databaseCode: KQ8 dateStart: 20121201 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2213-4239 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000970257 issn: 2213-4220 databaseCode: DOA dateStart: 20120101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVESC databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier) customDbUrl: eissn: 2213-4239 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000970257 issn: 2213-4220 databaseCode: GBLVA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Science Direct customDbUrl: eissn: 2213-4239 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000970257 issn: 2213-4220 databaseCode: .~1 dateStart: 20121201 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVLSH databaseName: Elsevier Journals customDbUrl: mediaType: online eissn: 2213-4239 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000970257 issn: 2213-4220 databaseCode: AKRWK dateStart: 20121201 isFulltext: true providerName: Library Specific Holdings – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 2213-4239 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000970257 issn: 2213-4220 databaseCode: RPM dateStart: 20120101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZokYAL4k14rALiBAp1YjuxjwtqVahaIcSKcrL8LKFLtspuQFz47Yzz0q5A2wunyMkkUT6PPZ81k88IvWBYeaD1eaKVcgm13CXaizQhlGmujWGs_Y_7-CQ_nNH3p-x0bauvUBPWyQN3wO0xwznxQkGkI9QqpSGgeJ_blBuIzUqH2RdzsbaYaudgUeBO5jPLUpLQLBtTmm1xV_k9aIFmbZEADRsVrwWlVrt_IzbtVLX_FwP9u5DyelNdqF8_1Xy-FqUObqGbPb2Mp91n3UZXXHUHXTvuE-h30f40NqF-ulo2y_isCRpXcD5e-Bj6TsOdQ649BjILpjUQ9R9lDcZ9JieGUC7uodnB_qe3h0m_k0JiAOtV4jVVlmJjFfbMO2hpoanNmM-1xY5bzxmmxnhKtNYFp9bD7OOVp9jiwllyH-1Wi8o9RLFnwlrDrOaMUqG8zlJnmfK54T5ogUUID1BK08uMh90u5nKoJ_smAX0Z0Jcd-hF6Od5y0WlsbDN-E_pnNAzy2O0JcBrZO428zGkiRIfelT3T6BgEPKrc9u7n4Any3JTta8PxbCHPawlrj3dSAPMlaRahZ4OjSBiqIf-iKrdoljKs7rigWVFssQELHkqVSIQedM41fiowbREUcyNUbLjdBhabV6ryaysZXhACS1PonFejg14O9aP_AfVjdCM8sivLe4J2V3XjngKPW-kJ2nn9O52gq9Ojj5-PJu0Ahtbs5MP0yx_t30h6 |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELbaIlEuiDfhGRAnUNg87MQ5lqrVFrq90Eq9WX4uoUuyym5AXPjtzOSxagRaJE5RnHGsfJ7YnzOTz4S8YaF0QOvTQElpA2q4DZTLoyChTHGlNWPtf9yzs3R6QT9esssdcjj8C4Nplf3Y343p7Wjdl0x6NCfLoph8jlGMLI4xlIbCaGyX3KAsznAF9v5XtPnQEuZZ2Cl-YoUAawzRzTbPq_iGsqBxmy9Acc_ia_NTK-M_mqZ2y9r9jYz-mVO535RL-fOHXCyuTVjHd8jtnmn6B93D3CU7trxHbs76WPp9cnTga0ylLlfNyp83KHcF5X7lfOhGBTWHsLsPvBZMa-Ds34sajPugjg-zev6AXBwfnR9Og35ThUAD7OvAKSoNDbWRoWPOwpnKFTUxc6kyoeXGcRZSrR1NlFIZp8bBQOSko6EJM2uSh2SvrEr7mPiO5cZoZhRnlObSqTiyhkmXau5QFswj4QCl0L3iOG58sRBDatlXAegLRF906Hvk7abKspPb2Gb8AftnY4hK2W1BVc9F7yqCac4Tl0tgSgk1UiogJM6lJuIauJ1UHqFD74qR48Gtim1tvwZPEFe6aJvF47wSV7WAZciJyIEEJ1HskVeDowh4azEUI0tbNSuBCz2eU_DWLTZgwTFrKfHIo865No8KpDtH8VyPZCO3G2ExvlIWX1r18CxJYJUKnfNu46D_hvrJ_6H0kuxPz2en4vTk7NNTcguvdPl5z8jeum7scyB0a_WifWF_A53-RnM |
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lj9MwELagKwEX3o_wUkCcQFmlsZ04x4J2tSDtigOVlpPl1yyhJV2lDQh-PePEqQisCpwSJ2NHnhnHnzXjz4S84KkChPV5opVyCbPCJRrKaUIZ10Ibw3m3j_v4JD-as3en_DSQRfu9MKP4fZeHVX3xtJ1ZF89nBa7O93KOsHtC9uYn72cf_eFx2ZQmLOsoGMM9LYcI5kVtjOagjqp_NBVdrhu4CHD-mTd5ta3P1fdvarn8ZVI6vNGnc607LkOfi7LYbzd63_z4jenxn_p7k1wP0DSe9b50i1xy9W1y5TgE3--Qg1lsfO51vW7X8Vnr-bHwebyCGO2useYQp48RCKNogyD_a9WgcIgCxQgDyrtkfnjw4c1REk5hSAzaaZOAZsqy1FiVAgeHJV1qZjMOubapExYET5kxwKjWuhDMAv65QAFLbVo4S--RSb2q3QMSAy-tNdxqwRkrFehs6ixXkBsBnkcsIulgF2kCRbk_KWMph1y0zxLVI716ZK-eiLzcVjnv-Tl2Cb_2xt4Kemrt7gFaQIaRKrkRgkKpEFpRZpXSiGAAcjsVBsGg0hFhg6vIgFJ69IFNVbu-_RzdSi5M1X3WX89WctFIXLe8lSWiZjrNIvJs8DqJw9zHblTtVu1a-pWhKFlWFDtkUEL4NCcakfu9p267iii99Gy7ESlGPjzSxfhNXX3q6MYLSnFZi8Z5tfX2v6v64X9JPyLXfKnP3XtMJpumdU8Q7G300zDMfwJMZ0ze |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+consensus+guideline+of+herbal+medicine+for+coronavirus+disease+2019&rft.jtitle=Integrative+medicine+research&rft.au=Lee%2C+Beom-Joon&rft.au=Lee%2C+Ju+Ah&rft.au=Kim%2C+Kwan-Il&rft.au=Choi%2C+Jun-Yong&rft.date=2020-09-01&rft.pub=Elsevier&rft.issn=2213-4220&rft.eissn=2213-4239&rft.volume=9&rft.issue=3&rft_id=info:doi/10.1016%2Fj.imr.2020.100470&rft_id=info%3Apmid%2F32691002&rft.externalDocID=PMC7335489 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2213-4220&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2213-4220&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2213-4220&client=summon |